Durect News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.08.17	DURECT Corporation Invites You to Join its Second Quarter 2017 Earnings Conference Call (PR Newswire)
28.06.17	Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo Pharma, and SciClone Pharma (PR Newswire)
22.06.17	DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR® (PR Newswire)
19.06.17	DURECT's Collaboration with Sandoz Clears HSR Review and is Effective (PR Newswire)
10.05.17	DURECT Corporation Announces First Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)
09.05.17	Gainers & Losers Of May 8: DRRX, CXRX, URGN, ARLX, TXMD... (RTTNews)
08.05.17	DURECT and Sandoz have Signed a $293 Million Development and Commercialization Agreement for POSIMIR® (SABER®-Bupivacaine) Covering the United States (PR Newswire)
04.05.17	DURECT Corporation Invites You to Join its First Quarter 2017 Earnings Conference Call (PR Newswire)
24.04.17	DURECT Announces Presentation of Data from a Phase 1b Study of DUR-928 in Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress™ 2017 (PR Newswire)
04.04.17	Pareteum Strengthens Sales Organization with Industry Veteran to Lead and Grow Worldwide Sales (PR Newswire)
03.04.17	DURECT to Present at the H.C. Wainwright NASH Investor Conference (PR Newswire)
20.03.17	How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United Therapeutics, DURECT, and SciClone Pharma (PR Newswire)
14.03.17	DURECT Corporation Announces Fourth Quarter and Full Year 2016 Financial Results and Update of Programs (PR Newswire)
24.02.17	DURECT Corporation Invites You to Join its Fourth Quarter 2016 Earnings Conference Call (PR Newswire)
31.01.17	Drug Makers Stocks on Investors' Radar -- Depomed, United Therapeutics, DURECT, and Orexigen Therapeutics (PR Newswire)
31.01.17	AEZS Inches Closer To D-Day, EYEG Catches Investors' Eyes, MCRB On Watch (RTTNews)
30.01.17	DURECT Corporation Announces Update on DUR-928 Development Program (PR Newswire)
21.12.16	Research Reports Coverage on Drug Makers Stocks -- Depomed, DURECT, United Therapeutics, and Amphastar Pharma (PR Newswire)
27.09.16	ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial (RTTNews)
26.09.16	Pain Therapeutics Gets CRL From FDA For REMOXY ER Extended-Release Capsules CII (RTTNews)
26.09.16	FDA Approves AMGN's 1st Biosimilar, MRNS On Track, All Ears For DRRX, PTIE (RTTNews)
30.08.16	Biotech Stocks Facing FDA Decision In September (RTTNews)
02.08.16	SMA Data Endears IONS To Investors, PFE Opens Wallet, Busy Months Ahead For DRRX (RTTNews)
04.07.16	BIND Gallups On Stalking Horse Offer, KBIO Is Back, ALNY Abuzz (RTTNews)
27.04.16	DRRX Prices Offering At $1.25/Share (RTTNews)
08.04.16	CLRB Gets A Breather, DRRX To PERSIST, ICPT Wins FDA Panel Vote Hands Down (RTTNews)
04.08.15	ISIS Does It Again, LXRX Shines On TELESTAR Data, ACRX Awaits EC Approval (RTTNews)
28.10.14	AEZS To Watch Out, RCPT Surges In Afterhours, CEMI Focuses On Ebola, PTIE Hurt (RTTNews)
27.10.14	Pfizer Ends Deal To Develop Remoxy, To Return Full Rights To Pain Therapeutics (RTTNews)
14.02.14	DRRX Feels Pain, Bitter Pill For MDCO, RTRX Soars To New High, TRGT On Watch (RTTNews)
13.02.14	FDA Rejects DURECT's Posidur NDA; Stock Tumbles 28% - Quick Facts (RTTNews)
13.02.14	After-market Movers For Feb 12 (CSCO, WFM, CBS, SKX, ANGI, ITRI, DRRX) (RTTNews)
08.01.14	CGEN Plans Busy Year, CytoDyn Gets Going, OREX Gets FDA Date, DRRX On A High (RTTNews)
22.10.13	DURECT Says Pfizer Will Continue Development Program For REMOXY (RTTNews)
22.10.13	Pfizer Proceeding with REMOXY® Development (PR Newswire)
27.09.13	DURECT Announces Changes to its Board of Directors (PR Newswire)
03.09.13	DURECT to Participate in Upcoming Healthcare Conferences (PR Newswire)
19.08.13	MNKD To Get Financing, PTIE, DRRX Vault, BMRN On Watch (RTTNews)
05.08.13	DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Durect

Aktien Top/Flop

Meistgelesene Nachrichten